Low-cost alternative for Flovent enters market after Sen. Hassan releases investigative report
DEALING WITH A DIFFICULT SITUATION, OR EVEN JUST BEFORE GOING HOME. A LOW COST ALTERNATIVE FOR COMMONLY USED ASTHMA MEDICATION WILL ENTER THE MARKET AFTER PRESSURE FROM SENATOR MAGGIE HASSAN GLAXOSMITHKLINE, PREVIOUSLY MANUFACTURED THE INHALER FLOVENT. …